LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Начало・Списък с акции・Champions Oncology Inc

C
Champions Oncology Inc

Затворен

СекторЗдравеопазване

5.82 1.04

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5.76

Максимум

5.97

Ключови измерители
By Trading Economics
Приходи	702K 236K
Продажби	1M 15M
P/E Средно за сектора	34.412 108.767
Марж на печалбата	1.57
Служители	213
EBITDA	1.1M 612K

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+100.67% upside

Дивиденти
By Dow Jones
Следващи печалби	10.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-26M 81M
Предишно отваряне	4.78
Предишно затваряне	5.82

Настроения в новините

By Acuity

50%

168 / 352 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

5.77 / 7.61 Подкрепа & съпротива

Champions Oncology Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.02.2026 г., 22:04 ч. UTC

Печалби

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26.02.2026 г., 23:55 ч. UTC

Пазарно говорене

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26.02.2026 г., 23:40 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26.02.2026 г., 23:37 ч. UTC

Пазарно говорене

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26.02.2026 г., 23:32 ч. UTC

Печалби

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26.02.2026 г., 23:19 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26.02.2026 г., 23:18 ч. UTC

Придобивния, сливания и поглъщания

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26.02.2026 г., 23:12 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

26.02.2026 г., 23:12 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26.02.2026 г., 23:01 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26.02.2026 г., 22:55 ч. UTC

Придобивния, сливания и поглъщания

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26.02.2026 г., 22:43 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

26.02.2026 г., 22:43 ч. UTC

Пазарно говорене

RBA Hike In March Is Being Underpriced -- Market Talk

26.02.2026 г., 22:33 ч. UTC

Придобивния, сливания и поглъщания

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26.02.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26.02.2026 г., 22:13 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26.02.2026 г., 21:59 ч. UTC

Печалби

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26.02.2026 г., 21:58 ч. UTC

Придобивния, сливания и поглъщания

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

26.02.2026 г., 21:49 ч. UTC

Печалби

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26.02.2026 г., 21:45 ч. UTC

Печалби

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Expects Market to Remain Highly Competitive

26.02.2026 г., 21:44 ч. UTC

Печалби

Coles Says Supermarket Customers Remain Value Oriented

26.02.2026 г., 21:43 ч. UTC

Печалби

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26.02.2026 г., 21:43 ч. UTC

Печалби

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26.02.2026 г., 21:42 ч. UTC

Придобивния, сливания и поглъщания

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26.02.2026 г., 21:41 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Champions Oncology Inc Прогноза

Ценова цел

By TipRanks

100.67% нагоре

12-месечна прогноза

Среден 12 USD 100.67%

Висок 12 USD

Нисък 12 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Champions Oncology Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Champions Oncology Inc през последните 3 месеца.

Техническа оценка

By Trading Central

5.77 / 7.61Подкрепа & съпротива

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Настроение

By Acuity

168 / 352 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.